$100 Trillion Future of Biotech: AI, China & Next Industrial Revolution | Jason Kelly, Ginkgo CEO

The era of human scientists is ending. Ginkgo Bioworks CEO Jason Kelly reveals how AI, robotics, and full lab automation are turning biology into software, and why China may outpace the West in the next biotech revolution.We unpack why synthetic biology failed, how AI can 100,000x innovation, and what happens when biology becomes fully automated: no pipettes, no benches, just data, machines, and code. Jason explains how Ginkgo is redefining biotech by separating bench biology from code biology, automating experiments, and letting AI drive discovery.Hosted by Mgoes → https://x.com/m_goes_distance-—00:00 - Origins of Synthetic Biology10:31 - Why Programming Biology Fails18:23 - Chemicals, Protein, CBD, Leather22:10 - Human Enhancement Tech Is Here28:20 - Full Lab Automation, Robotics, AI36:00 - 100,000x Faster Innovation41:40 - Will AI Replace Scientists?48:52 - Regulations Are Killing Biotech56:03 - Will China Get There First?---The Accelerate Bio Podcast explores the future of human potential in the age of Artificial Intelligence. Subscribe for bi-weekly deep-dive interviews with founders, investors, and scientists shaping deeptech, science, AI, biotechnology, human enhancement, and more.Brought to you by BiohackerDAO - A community dedicated to exploring and funding frontier technologies in human enhancement.-—Keywords: AI biotech, lab automation, Ginkgo Bioworks, Jason Kelly, synthetic biology, AI in science, future of biology, biomanufacturing, AI wetlabs, robotic labs, China biotech, TechBio, biological AI, automation in biotech, human enhancement, longevity, synbio.

There are no comments yet.

Please log in to write the first comment.